Liposomal encapsulation of chelated actinium-225 and uses thereof

Details for Australian Patent Application No. 2001275489 (hide)

Owner Sloan-Kettering Institute For Cancer Research

Inventors Mcdevitt, Michael R.; Scheinberg, David; Thomas, James Louis; Sgouros, George

Agent Callinan

Pub. Number AU-B-2001275489

PCT Pub. Number WO01/97859

Priority 60212186 16.06.00 US

Filing date 15 June 2001

Wipo publication date 2 January 2002

Acceptance publication date 27 January 2005

International Classifications

A61K 051/00 Preparations containing radioactive substances for use in therapy or testing

A61K 103/00

A61K 009/127 Medicinal preparations characterised by special physical form - Liposomes

A61K 051/12 Preparations containing radioactive substances for use in therapy or testing - characterised by a special physical form, e.g. emulsion, microcapsules, liposomes

Event Publications

27 January 2005 Application Accepted

  Published as AU-B-2001275489

26 May 2005 Standard Patent Sealed

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001275490-MHC peptides over-expressed on prostate cancer cells and methods of use

2001275488